ArticlePDF AvailableLiterature Review

Comprehensive review on the molecular genetics of autosomal recessive primary microcephaly (MCPH)

Wiley
Genetics Research
Authors:

Abstract and Figures

Primary microcephaly (MCPH) is an autosomal recessive sporadic neurodevelopmental ailment with a trivial head size characteristic that is below 3–4 standard deviations. MCPH is the smaller upshot of an architecturally normal brain; a significant decrease in size is seen in the cerebral cortex. At birth MCPH presents with non-progressive mental retardation, while secondary microcephaly (onset after birth) presents with and without other syndromic features. MCPH is a neurogenic mitotic syndrome nevertheless pretentious patients demonstrate normal neuronal migration, neuronal apoptosis and neural function. Eighteen MCPH loci (MCPH1–MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin , WDR62 , CDK5RAP2 , CASC5 , ASPM , CENPJ , STIL , CEP135 , CEP152 , ZNF335 , PHC1 , CDK6 , CENPE , SASS6 , MFSD2A , ANKLE2 , CIT and WDFY3 , clarifying our understanding about the molecular basis of microcephaly genetic disorder. It has previously been reported that phenotype disease is caused by MCB gene mutations and the causes of this phenotype are disarrangement of positions and organization of chromosomes during the cell cycle as a result of mutated DNA, centriole duplication, neurogenesis, neuronal migration, microtubule dynamics, transcriptional control and the cell cycle checkpoint having some invisible centrosomal process that can manage the number of neurons that are produced by neuronal precursor cells. Furthermore, researchers inform us about the clinical management of families that are suffering from MCPH. Establishment of both molecular understanding and genetic advocating may help to decrease the rate of this ailment. This current review study examines newly identified genes along with previously identified genes involved in autosomal recessive MCPH.
Content may be subject to copyright.
1. Introduction
Microcephaly is a rare neurodevelopment
disorder defined as biparietal diameter (BPD)
and for gestational phase exhausting
Brazilian-established allusion sorts small
head size characteristic that is below 3-4
standard unconventionalities and reduced
cerebral cortex region of brain (Araujo Junior
et al., 2014). Microcephaly patients may or
may not have mental retardation with mild to
severe conditions and such by way of squat
physique, annexations or hereditary earshot
loss are surplus sorts (Darvish et al., 2010).
In two common forms it can be classified;
primary microcephaly (by birth) plus
secondary microcephaly (onset after birth)
with and without other syndromic features
(COWIE, 1960). A prenatal developmental
neurogenic disorder is Primary Microcephaly
whereas secondary microcephaly is
concomitant through reformist
neurodegenerative bugs.
Autosomal recessive primary microcephaly
(MCPH) is a neurogenic mitotic syndrome
through conventional, neuronal apoptosis
neuronal voyage and neural role of
exaggerated patients. There are various
genetic and environmental causes including
Chromosomal aberrations, dented DNA as a
consequence of anxious mitotic spindle
alignment, impulsive chromosomal
abridgment, reformed indicating retort and
Maternal overconsumption of alcohol,
congenital infections and drugs taken during
pregnancy, intellect harm, metabolic
disorders such as alaninuria or revelation to
teratogenic remedies and substances taken
during pregnancy (Darvish et al., 2010)
(Faheem, Naseer, Rasool, Chaudhary,
Kumosani, Ilyas, Pushparaj, Ahmed,
Algahtani, & Al-Qahtani, 2015). Secondary
microcephaly frequently basis metabolic
ailments somewhat than primary
microcephaly and are regularly concomitant
with surplus signs and experimental signs
(Hagen et al., 2014). Inquiries of metabolic
screening, if necessary, must primarily
emphasis on maternal phenylketonuria,
phosphoglycerate dehydrogenase paucity,
and Amish fatal microcephaly (2-
ketoglutaric aciduria) as secondary bases of
microcephaly (Kelley, Robinson,
Puffenberger, Strauss, & Morton, 2002).
Sterol biosynthesis disorders,
mitochondriopathies, and hereditary
disorders of glycosylation are provoked by
the defects the sporadic metabolic bases of
primary microcephaly embrace serine
biosynthesis (von der Hagen et al., 2014).
MCPH the prevalence that arrays since
1:30,0001: 250,000 per live-birth reliant on
the population (Zaqout, Morris-Rosendahl, &
Kaindl, 2017). In Asian and Arab populations
where, consanguineous marriages are mutual
but MCPH is scarcer in Whites than both (M.
Farooq et al, 2009). Worldwide MCPH has
been recounted in additional than 300
families and distinct patients; conversely,
frequently with merely scrubby phenotype
similes. Separately from intellectual infirmity
(IQ between 30 and 7080), hyperactivity
and devotion deficit, dialog deferral, and a
tapered slanting forehead, MCPH patients
ordinarily do not have any auxiliary
neurological ciphers (Bhat et al., 2011;
Kaindl et al., 2010; Kraemer et al., 2016;
Passemard et al., 2009). For Autosomal
Recessive Primary Microcephaly to date 18
loci and residing genes are guilty which are
described (Figure 1) and their cytogenic
location are summarized in Figure 2
(Faheem, Naseer, Rasool, Chaudhary,
Kumosani, Ilyas, Pushparaj, Ahmed,
Algahtani, & Al-Qahtani, 2015) ; (Zaqout et
al., 2017). The utmost corporate basis of
MCPH are Biallelic mutations in ASPM
(68.6%), followed by those in the WDR62
gene (14.1%) and MCPH1 gene (8%). To
exist given the lack of mutations more
genetic loci are stagnant predictable in
known loci in circa 50 to 75% of western
Europeans or North Americans with MCPH
and almost 20 to 30% of Indians or Pakistanis
with MCPH (Verloes, Drunat, Gressens, &
Passemard, 1993); (Sajid Hussain et al.,
2013).
The up-to-date knowledge on the molecular
genetics of autosomal recessive primary
microcephaly (MCPH) counting the newly
notorious locus with its gene (MCPH1-
MCPH18) in this review article we
expansively discuss. The corresponding
genes and the proteins encoded by these
genes, their probable role in the emerging
brain (Table 1) and stated mutations of these
genes explicitly in Pakistani population
(Table 2) of the MCPH genes auxiliary, we
review. In toting, through human brain
evolutionary the latent for these genes to
achieve numerous intellectual parts methods
are conversed.
2. Molecular Genetics
i. MCPH1 (Microcephalin)
MCPH1 encodes the important regulator of
chromosome condensation (BRCT BRCA1
C terminus) “Microcephalin protein”.
Microcephalin protein consists of 3 BCRT
domains and conserved tandem repeats of
phospho-peptide interacting amino acids
(Faheem, Naseer, Rasool, Chaudhary,
Kumosani, Ilyas, Pushparaj, Ahmed,
Algahtani, Al-Qahtani, et al., 2015; Pulvers,
Journiac, Arai, & Nardelli, 2015). This gene
is localized on chromosome 8p23 composing
14 exons, 835 amino acids, genome size and
molecular weight of 241,905 bp and 92877
Da respectively. It exists in three isoforms
obtained after splicing and an open reading
frame of about 8,032 bp (Faheem, Naseer,
Rasool, Chaudhary, Kumosani, Ilyas,
Pushparaj, Ahmed, Algahtani, & Al-Qahtani,
2015); (Venkatesh et al., 2013).
Microcephalin protein being a pleiotropic
factor imparts its significant effect in
neurogenesis; it regulates the division of
neuroprogenitor cells and prevents them from
exhaustion i.e. from microcephaly. It is the
significant regulator of telomere integrity and
tangled in DNA damage repair mechanism.
Also act as tumor suppressor in several
human cancers, in germline functions and
performs its function in brain development
and in the regulation of the normal size of
cerebral cortex (Venkatesh et al, 2013;
Pulvers et al, 2015). Some of studies have
reported that MCPH1 gene is involved in
brain size determination and as positive
selector for primate linage (Stephen H.
Montgomery & Nicholas I. Mundy, 2014; S.
H. Montgomery & N. I. Mundy, 2014). It was
considered that MCPH1 being a common
causative agent of microcephaly covering
both environmental and genetic causative
areas of microcephaly. It leads to the drastic
reduction of brain size, especially in the
region of cerebral cortex and short stature.
Magnetic resonance imaging (MRI) of the
patients revealed that the existence of
cerebral deformations, such as gyral pattern
observed in the brain and corpus collasum
hypoplasia. It is basically caused due to
premature switching asymmetric division
neuroprogenitors from symmetric division.
Mutation in MCPH1 causes the mis-
regulated chromosomal condensation,
genomic instability, delayed de-condensation
post mitosis (Liu, Zhou, & Wang, 2016). The
successful experiments for MCPH1-mouse
model generation reported mis-regulated
mitotic chromosome condensation,
deficiency in DNA repair, defective spindle
orientation and a reduced skull size with the
approximately 20% reduction in body weight
(Faheem, Naseer, Rasool, Chaudhary,
Kumosani, Ilyas, Pushparaj, Ahmed,
Algahtani, & Al-Qahtani, 2015; Zhou et al.,
2013).
ii. MCPH2 (WDR62)
The WDR62 gene, encodes the “WD repeat-
containing protein 62”, localized on
chromosome 19q13.12 composing 35
exons,1518 amino acids, genomic size of
50,230 bp with the molecular mass of 165954
Da and has four known spliced isoforms
(Faheem, Naseer, Rasool, Chaudhary,
Kumosani, Ilyas, Pushparaj, Ahmed,
Algahtani, & Al-Qahtani, 2015; Pervaiz &
Abbasi, 2016). WDR62 consists of a WD40
domain, a JNK docking domain and a MKK7
binding domain. It is a scaffold protein
involved in the pathway of the c-Jun N-
terminal kinase (Bastaki et al., 2016) and
highly expressed in neuronal precursors,
developing brain within post mitotic neurons
and in the ventricular and sub ventricular
zone in forebrain region (Pervaiz & Abbasi,
2016). This protein plays a significant part in
the formation of several cellular layers in the
cerebral cortex region during embryogenesis.
It plays a compelling character in the
proliferation and migration of neurons and in
the duplication of mother-centriole-
dependent centriole (Sgourdou et al., 2017).
Several findings revealed that WDR62
functions are somehow similar to ASPM
which is another MCPH gene. Moreover,
studies revealed that WDR62 gene, as it plays
an important part in brain cortical
development, is involved in human brain
evolutions indicted by dramatic inflation in
the size of cerebral cortex (Pervaiz et al,
2016). Mutation in WDR62 can lead to wide
range of disorders including: microcephaly,
cognitive disability, cortical malformations
and multiple transcript variants by alternative
splicing. Majority of mutations found in
WDR62 which revealed that it accounts for
around 10 % of all the cases of microcephaly.
Homozygous or heterozygous mutation in
WDR62 causes autosomal recessive primary
microcephaly with or without cortical
malformations (Naseer et al., 2017). Patients
with these mutations have HC ranging from
normal to severe. MRI of the patients with
these mutations shows numerous cortical
malformations such as pachygyria,
impulsivity, polymicrogyria, aggretion,
hypoplasia of corpus collasum, delayed
psychomotor development , simplified gyral
patterns, mental retardation with reduced
head size and lissencephaly (Faheem,
Naseer, Rasool, Chaudhary, Kumosani, Ilyas,
Pushparaj, Ahmed, Algahtani, & Al-Qahtani,
2015) (Bastaki et al., 2016; Farag et al.,
2013). Disruption of WDR62 in mouse
model altered the late neurogenesis
neocortical progenitors proliferation process
which further depicts asymmetric
centrosome inheritance abnormalities leading
towards the microcephaly in mice, and
impairs the mitotic cycle progression,
temporarily arrest at pro metaphase and
defects in spindle pole localization of
WDR62 (Farag et al., 2013; Sgourdou et al.,
2017).
... These genes produce proteins found in the centrosome and spindle poles, indicating that mutations affecting these structures have a significant impact on brain size. In other words, disruptions in these specific proteins have a particular vulnerability in the development and size of the brain [16]. The diverse genetic causes of MCPH highlight its complex nature and the involvement of various molecular pathways in brain development. ...
Article
Full-text available
Background Primary autosomal recessive microcephaly (MCPH) is a rare developmental disorder characterized by cognitive impairment, delayed neurodevelopment, and reduced brain size. It is a genetically heterogeneous condition, and several genes have been identified as associated with MCPH. Methods and results In this study, we utilized whole-exome sequencing (WES) to identify disease-causing variations in two brothers from an Iranian family affected by MCPH, who had consanguineous parents. In the patients, we detected a novel homozygous missense mutation (c.806A > G, p.Gln269Arg) in the TEDC1 gene in one of the patients. Co-segregation analysis using Sanger sequencing confirmed that this variant was inherited from parents. The identified variant was evaluated for its pathogenicity and novelty using various databases. Additionally, bioinformatics tools were employed to predict the three-dimensional structure of the mutant TEDC1 protein. Conclusions This study presents the second documented report of a mutation in the TEDC1 gene associated with MCPH. The identification of this novel biallelic mutation as a causative factor for MCPH in the proband further underscores the utility of genetic testing techniques, such as WES, as reliable diagnostic tools for individuals with this condition.
... It is an autosomal recessive sporadic neurodevelopmental disorder where it involved in G2-M checkpoint arrest and DNA damage response. [49][50][51] Module 4 consists of a seed protein, CLTCL1 (clathrin, heavy chain-like 1) (Fig. 3), has the score value 10, and consists of 10 interacting proteins and 45 edges. CLTCL1 belongs to the clathrin family of genes which codes for the protein that consists of 1640 amino acid sequences. ...
Article
Full-text available
β-catenin (CTNNB1), a scaffold protein, plays a vital role in embryonic development, adult tissue homeostasis, neurodegenerative diseases, bone diseases, chronic obstructive pulmonary diseases, wound healing, and pigment disorders. β-catenin is the crucial component in the Wnt-signaling pathway. β-catenin levels in the cytosol balance the Wnt-signaling pathway. The activated Wnt-signaling pathway allows the accumulation of β-catenin in the nucleus and further act as a promoter to initiate transcription of several oncogenes responsible for carcinogenesis. In the present study, we have used a systems biology approach to map β-catenin interactors. Primary protein-protein interaction databases such as PubChem, CTD, and STITCH databases were used to collect all the experimentally valid β-catenin interactors and their subcellular location was traced using UniProtKB database. The interactome was constructed and analyzed by utilizing STRING and Cytoscape tools. MCODE, Cytoscape tool, was utilized to construct and analyze the sub-networks. Correlation between modular seed proteins and β-catenin was studied using UALCAN database. Functional enrichment analysis was done using DAVID database. Cytohubba, a Cytoscape tool was utilized to identify the top gene interactors of β-catenin. Further, the expression and gene ontology of each β-catenin gene interactor were analyzed using UALCAN and CleuGO tools. The analysis reveals β-catenin interactors, TP53, EP300, RPS27A, UBC, HDAC1, SRC, AKT1, EGFR, HSP90AA1, and CREBBP as the first top gene interactors. This study uses a systems biology-driven approach and successfully identifies and understands the biological roles of the top β-catenin interactors.
... Biallelic alterations in ASPM are the most frequent etiology of MCPH (68.6%), followed by changes in WDR62 quality (14.1%) and MCPH1 gene (8%). Given the lack of mutations in the known loci in roughly 50-75% of Western Europeans or North Americans with MCPH and roughly 20-30% of Indians or Pakistanis with MCPH, further hereditary loci are still expected to exist (Hussain et al., 2013;Naveed et al., 2018). Primarily due to the high proportion of consanguineous marriages, genetic diseases with recessive modes of transmission are prevalent in some isolated groups living in rural Pakistan. ...
Article
Full-text available
Neurodevelopmental disorders (NDDs) are a class of disorders affecting brain development and function; they are characterized by extensive genetic and clinical variability. We performed clinical, genetic, biochemical, and molecular analyses on two consanguineous families with microcephaly exhibiting an NDD. Detailed clinical investigation and molecular diagnosis were performed using whole-exome sequencing (WES), followed by Sanger sequencing for the affected families. WES revealed disease-causing homozygous variants in two families associated with microcephaly and NDDs. In family A and family B, we identified two previously reported homozygous variants (c.3978G>A; Trp1326* and c.4309C>A; p.Arg1437Ser) in the ASPM gene. Both the variants were further confirmed using bi-directional Sanger sequencing. In the present study, we presented literature review regarding the NDDs and microcephaly associated with ASPM pathogenesis. These findings contribute to studies of genotype–phenotype correlation, genetic counseling of the families, inclusion of ASPM in newborn screening, and further understanding of human brain function and development.
... Interestingly, we found that among the main downregulated genes were some classic microcephaly-causing genes, such as CENPJ, negatively regulated in three datasets, as well as ASPM, CENPE, and CEP152 affected in two data sets each. When mutated, these four genes cause primary microcephaly, characterized by microcephaly present at birth, due to the absence or reduced activity of the proteins that they encode (Faheem et al. 2015;Naveed et al. 2018). Therefore, it seems that the impact of ZIKV on the expression of these genes and, consequently, on the function of their proteins represents a phenocopy of genetic mutations that lead to microcephaly. ...
Article
Full-text available
Zika virus (ZIKV) is a neurotropic teratogen that causes congenital Zika syndrome (CZS), characterized by brain and eye anomalies. Impaired gene expression in neural cells after ZIKV infection has been demonstrated; however, there is a gap in the literature of studies comparing whether the differentially expressed genes in such cells are similar and how it can cause CZS. Therefore, the aim of this study was to compare the differential gene expression (DGE) after ZIKV infection in neural cells through a meta-analysis approach. Through the GEO database, studies that evaluated DGE in cells exposed to the Asian lineage of ZIKV versus cells, of the same type, not exposed were searched. From the 119 studies found, five meet our inclusion criteria. Raw data of them were retrieved, pre-processed, and evaluated. The meta-analysis was carried out by comparing seven datasets, from these five studies. We found 125 upregulated genes in neural cells, mainly interferon-stimulated genes, such as IFI6, ISG15, and OAS2, involved in the antiviral response. Furthermore, 167 downregulated, involved with cellular division. Among these downregulated genes, classic microcephaly-causing genes stood out, such as CENPJ, ASPM, CENPE, and CEP152, demonstrating a possible mechanism by which ZIKV impairs brain development and causes CZS.
Article
Background: Genetic microcephaly is linked to an increased risk of developmental disabilities, epilepsy, and motor impairment. The aim of this study is to describe the spectrum of identifiable genetic etiologies, clinical characteristics, and radiologic features of genetic microcephaly in patients referred to a tertiary center in Saudi Arabia. Method: This is a retrospective chart review study of all patients with identifiable genetic microcephaly presenting to a tertiary center in Saudi Arabia. The patients’ demographics, clinical, laboratory, radiologic, and molecular findings were collected. Results: Of the total 128 cases referred, 52 cases (40%) had identifiable genetic causes. Monogenic disorders were found in 48 cases (92%), whereas chromosomal disorders were found in only 4 cases (8%). Developmental disability was observed in 40 cases (84%), whereas only 8 cases (16%) had borderline IQ or mild developmental delay. Epilepsy was seen in 29 cases (56%), and motor impairment was seen in 26 cases (50%). Brain magnetic resonance imaging (MRI) revealed abnormalities in 26 (50%) of the cohort. Hereditary neurometabolic disorders were seen in 7 (15%) of the 48 cases with monogenic disorders. The most common gene defect was ASPM, which is responsible for primary microcephaly type 5 and was seen in 10 cases (19%). A novel PLK1 gene pathogenic mutation was seen in 3 cases (6%). Conclusion: Single gene defect is common in this Saudi population, with the ASPM gene being the most common. Hereditary neurometabolic disorders are a common cause of genetic microcephaly. Furthermore, we propose the PKL1 gene mutation as a possible novel cause of genetic microcephaly.
Article
Focal cortical dysplasias (FCDs) include a spectrum of anomalies of cortical development that consist in one or more areas with altered lamination and in some cases, neurons of abnormal morphology. Clinically, these structural anomalies led to arise of epilepsy, which is more often a focal, drug-resistant type with onset in pediatric or adolescent age. Occasionally, other symptoms have been reported in patients with FCDs, such as headache, movement disorders, and cognitive impairment. According to International League against Epilepsy scheme of 2011, three main subtypes of FCD can be distinguished, based of anatomopathological feature, radiological signs, and clinical expression. Magnetic resonance imaging (MRI), fluorodeoxyglucose positron emission tomography, and neurophysiology are the cornerstones of diagnosis, although their negativity cannot exclude FCD in symptomatic patients, especially in FCD type I which often is elusive. In MRI, the main finding is the irregularity of the cortical–subcortical signal, specifically reduction of cortical thickness and absence of clear demarcation between gray and white matters, which is strongly diagnostic for FCD. Epilepsy related to FCD is difficult to manage and until now there is not a clear direction for treatment's rules. FCD shows poor response to antiepileptic drugs (AEDs), and there is no evidence of some AED that has proved more efficacy than others in patients with FCDs. Considering genetical and pathophysiological recent acquisitions, mammalian target of rapamycin inhibitors may play a fundamental role in future treatment of FCDs, but nowadays, surgery still remains the main weapon, with 50% of patients who undergo neurosurgery.
Article
Microcephaly, a form of cortical cortex malformation, results from abnormal cellular production and proliferation, identified when the occipital frontal head circumference (OFC) falls two or more standard deviations (SDs) below the expected average for age, gender, and population. Severity is classified based on SD: mild (OFC < 2 SD) or severe (OFC < 3 SD). While microcephaly can lead to developmental delay, intellectual disability, epilepsy, and cerebral palsy, not all cases exhibit these issues. Classified as primary/congenital or secondary/postnatal, microcephaly can stem from genetic or acquired factors in both types. Congenital microcephaly origins vary, while secondary microcephaly is characterized by normal OFC at birth, followed by a decrease within the first year, often associated with progressive cognitive and motor impairments. Primary hereditary microcephaly (MCPH), or microcephaly vera, is genetically diverse, with 28 related genes (MCPH1 to MCPH28) encoding proteins linked to centrosomes and progenitor cell mitosis in the brain ventricle's neuroepithelium. Defects in deoxyribonucleic acid (DNA) repair pathways (e.g., NBN, FANCA, ATR, ATM genes) can lead to microcephaly by impairing DNA repair. Enzyme deficiencies in metabolic pathways may also contribute, causing toxic metabolite accumulation or essential metabolite loss (microcephaly of metabolic origin). Acquired congenital microcephaly may result from ischemic or infectious processes, drugs, radiation, maternal diseases during pregnancy, with damage influenced by fetal genetics, environmental interactions, developmental stage, and exposure intensity/duration. Diagnostic workup includes electroencephalogram, ophthalmological, auditory, magnetic resonance imaging, metabolic, echocardiogram, and infection screening tests, alongside genetic evaluations like cytogenetic studies, fluorescence in situ hybridization, comparative genomic microarray-hybridization, single-nucleotide microarray-polymorphism, and exome sequencing. Symptomatic treatment is available, and genetic counseling is crucial for affected families.
Article
Ankyrin repeat and LEM domain-containing 2 (ANKLE2) is a scaffolding protein with established roles in cell division and development, the dysfunction of which is increasingly implicated in human disease. ANKLE2 regulates nuclear envelope disassembly at the onset of mitosis and its reassembly after chromosome segregation. ANKLE2 dysfunction is associated with abnormal nuclear morphology and cell division. It regulates the nuclear envelope by mediating protein-protein interactions with barrier to autointegration factor (BANF1; also known as BAF) and with the kinase and phosphatase that modulate the phosphorylation state of BAF. In brain development, ANKLE2 is crucial for proper asymmetric division of neural progenitor cells. In humans, pathogenic loss-of-function mutations in ANKLE2 are associated with primary congenital microcephaly, a condition in which the brain is not properly developed at birth. ANKLE2 is also linked to other disease pathologies, including congenital Zika syndrome, cancer and tauopathy. Here, we review the molecular roles of ANKLE2 and the recent literature on human diseases caused by its dysfunction.
Article
Full-text available
Primary microcephaly (MCPH) is a congenital, static, and non-progressive neurodevelopmental disorder associated with reduced head circumference (< 4 standard deviations). About 28 known genes are associated with the MCPH. The study was carried out to probe molecular basis and genetic variants involved with MCPH in an affected Pakistani family to better understand the etiology and prevalence of the disorder. The individuals of the ascertained Pakistani family presented primary microcephaly, along with intellectual disability, speech disorder, and motor delay. By ensuring ethical compliance and patient consent, blood samples were collected from affected individuals. DNA was extracted using the salting out method followed by whole-exome sequencing and Sanger sequencing to identify causative genetic variants or mutations. In silico studies were performed to predict the effect of mutations on the structure of target proteins. Two missense allelic variants (NM_024596.5: c.139G>C and NM_024596.5: c.211G>C) of MCPH1 gene were detected in a Pakistani family. In silico analysis was performed to evaluate the effect of the mutant protein. The mutation in genes affects the activities of proteins NM_024596: p. Val47Leu and NM_024596: p. Val71Leu respectively by disruption in protein structure. The mutations were predicted to have higher pathogenicity scores and have significantly influenced the prevalence of MCPH. We reported two novel genetic variants for the first time from the Pakistani population causing MCPH. Mutations in MCPH1 gene are one of the major causes of MCPH in the populations where consanguine marriages are common. The novel mutations identified in this study will help to understand the etiology of the disorder and the mechanisms of mutated proteins.
Article
Full-text available
Background: Primary microcephaly (MCPH) is a rare developmental defect characterized by impaired cognitive functions, retarded neurodevelopment and reduced brain size. It is genetically heterogeneous and more than 17 genes so far have been identified that are associated with this disease. Objective: To study the genetic defect in a consanguineous Saudi family with primary microcephaly. Design: Cross-sectional clinical genetics study of a Saudi family. Setting: Medical genomics research center. Patients and methods: Blood samples collected from six members of a family of healthy consanguineous parents were analyzed by whole exome sequencing to identify the underlying pathogenic mutations in two members of the family (23-year-old female and 7-year-old male) who presented with primary microcephaly, intellectual disability, delayed psychomotor development and walking difficulty, speech impedi-ments and seizures. Main outcome measure(s): Detection of mutation in the WD repeat domain 62 (WDR62) gene in a family segregating autosomal recessive primary microcephaly. Results: The exome variant analysis identified a novel missense mutation (c.3878C > A) in WDR62 gene in exon 30 resulting in amino acid change from alanine to aspartate (p.Ala1293Asp). Further validation in the affected patients and healthy members of family and 100 unrelated healthy persons as controls confirmed it to be pathogenic. Conclusions: Functional impairment of the WDR62 gene can lead to severe neurodevelopmental de-fects, brain malformations and reduced head size. A missense mutation of exon 30 changed alanine to aspartate in the WDR62 protein leading to the typical MCPH phenotype. Limitations: Mutation was identified in a single family.
Article
Full-text available
A recent outbreak of Zika virus in Brazil has led to a simultaneous increase in reports of neonatal microcephaly. Zika targets cerebral neural precursors, a cell population essential for cortical development, but the cause of this neurotropism remains obscure. Here we report that the neural RNA-binding protein Musashi-1 (MSI1) interacts with the Zika genome and enables viral replication. Zika infection disrupts the binding of MSI1 to its endogenous targets, thereby deregulating expression of factors implicated in neural stem cell function. We further show that MSI1 is highly expressed in neural progenitors of the human embryonic brain, and is mutated in individuals with autosomal recessive primary microcephaly. Selective MSI1 expression in neural precursors could therefore explain the exceptional vulnerability of these cells to Zika infection.
Article
Full-text available
Background Zika virus (ZIKV) has been associated with a variety of neuropathologies, including microcephaly. We hypothesize that ZIKV genes activate host microRNAs (miRNAs) causing dysfunctional development of human fetal brains. Objectives/methods A bioinformatics search for miRNA genome-wide binding sites in the prototypic ZIKV (strain MR766) was undertaken to hunt for miRNAs with significant similarities with MCPH genetic sequences responsible for inducing MCHP in human fetal brains. Results Six ZIKV miRNAs were found to share mutual homology with 12 MCPH genetic sequences responsible for inducing MCPH. Noteworthy was miR-1304, which expressed 100% identity to six different MCPH genes. Conclusions We suggest that following infection of fetal neurons ZIKV may modulate the action of various miRNAs, and miR-1304 in particular, resulting in microcephaly.
Article
Full-text available
Recessive mutations in WD repeat domain 62 (WDR62) cause microcephaly and a wide spectrum of severe brain malformations. Disruption of the mouse ortholog results in microcephaly underlain by reduced proliferation of neocortical progenitors during late neurogenesis, abnormalities in asymmetric centrosome inheritance leading to neuronal migration delays, and altered neuronal differentiation. Spindle pole localization of WDR62 and mitotic progression are defective in patient-derived fibroblasts, which, similar to mouse neocortical progenitors, transiently arrest at prometaphase. Expression of WDR62 is closely correlated with components of the chromosome passenger complex (CPC), a key regulator of mitosis. Wild type WDR62, but not disease-associated mutant forms, interacts with the CPC core enzyme Aurora kinase B and staining of CPC components at centromeres is altered in patient-derived fibroblasts. Our findings demonstrate critical and diverse functions of WDR62 in neocortical development and provide insight into the mechanisms by which its disruption leads to a plethora of structural abnormalities.
Article
Full-text available
Mutations in citron (CIT), leading to loss or inactivation of the citron kinase protein (CITK), cause primary microcephaly in humans and rodents, associated with cytokinesis failure and apoptosis in neural progenitors. We show that CITK loss induces DNA damage accumulation and chromosomal instability in both mammals and Drosophila. CITK-deficient cells display “spontaneous” DNA damage, increased sensitivity to ionizing radiation, and defective recovery from radiation-induced DNA lesions. In CITK-deficient cells, DNA double-strand breaks increase independently of cytokinesis failure. Recruitment of RAD51 to DNA damage foci is compromised by CITK loss, and CITK physically interacts with RAD51, suggesting an involvement of CITK in homologous recombination. Consistent with this scenario, in doubly CitK and Trp53 mutant mice, neural progenitor cell death is dramatically reduced; moreover, clinical and neuroanatomical phenotypes are remarkably improved. Our results underscore a crucial role of CIT in the maintenance of genomic integrity during brain development.
Article
Primary microcephaly (MCPH, for "microcephaly primary hereditary") is a disorder of brain development that results in a head circumference more than 3 standard deviations below the mean for age and gender. It has a wide variety of causes, including toxic exposures, in utero infections, and metabolic conditions. While the genetic microcephaly syndromes are relatively rare, studying these syndromes can reveal molecular mechanisms that are critical in the regulation of neural progenitor cells, brain size, and human brain evolution. Many of the causative genes for MCPH encode centrosomal proteins involved in centriole biogenesis. However, other MCPH genes fall under different mechanistic categories, notably DNA replication and repair. Recent gene discoveries and functional studies have implicated novel cellular processes, such as cytokinesis, centromere and kinetochore function, transmembrane or intracellular transport, Wnt signaling, and autophagy, as well as the apical polarity complex. Thus, MCPH genes implicate a wide variety of molecular and cellular mechanisms in the regulation of cerebral cortical size during development.
Article
Nonsense mutations in the ASPM gene have been most frequently identified among familial microcephaly patients. Depletion of the Drosophila orthologue causes spindle pole unfocusing during mitosis in multiple cell types. However, it remains unknown whether human ASPM has a similar function. Here, using CRISPR-based gene knockout (KO) and RNA interference combined with auxin-inducible degron, we show that ASPM functions in spindle pole organisation during mitotic metaphase redundantly with another microcephaly protein CDK5RAP2 (also called CEP215) in human tissue culture cells. Deletion of the ASPM gene alone did not affect spindle morphology or mitotic progression. However, when the pericentriolar material protein CDK5RAP2 was depleted in ASPM KO cells, spindle poles were unfocused during prometaphase and anaphase onset was significantly delayed. The phenotypic analysis of CDK5RAP2-depleted cells suggested that the pole-focusing function of CDK5RAP2 is independent of its known function to localise the kinesin-14 motor HSET or activate the γ-tubulin complex. Finally, a hypomorphic mutation identified in ASPM microcephaly patients similarly caused spindle pole unfocusing in the absence of CDK5RAP2, suggesting a possible link between spindle pole disorganisation and microcephaly.
Article
Covalent histone modifications play an essential role in gene regulation and cellular specification required for multicellular organism development. Monoubiquitination of histone H2A (H2AUb1) is a reversible transcriptionally repressive mark. Exchange of histone H2A monoubiquitination and deubiquitination reflects the succession of transcriptional profiles during development required to produce cellular diversity from pluripotent cells. Germ-line pathogenic variants in components of the H2AUb1 regulatory axis are being identified as the genetic basis of congenital neurodevelopmental disorders. Here, we review the human genetics findings coalescing on molecular mechanisms that alter the genome-wide distribution of this histone modification required for development.
Article
Inherited microcephaly exposes Zika culprit Microcephaly has been the terrifying hallmark of the recent outbreak of Zika virus (ZIKV) in the Americas. How the virus damages brain development in the fetus is enigmatic. Chavali et al. found that in congenital microcephaly, mutations in a neural precursor protein, Musashi-1 (MSI1), impede RNA binding to neural stem cell targets, resulting in abnormal brain development (see the Perspective by Griffin). MSI1 also binds ZIKV RNA to amplify viral replication in cells. This interaction could put a pregnant woman at risk of giving birth to a microcephalic child. Furthermore, MSI1 is expressed at high levels in the mouse testis, which may explain the sexual transmission of this virus. Science , this issue p. 83 ; see also p. 33
Article
Autosomal recessive primary microcephaly (MCPH; MicroCephaly Primary Hereditary) is a genetically heterogeneous neurodevelopmental disorder characterized by a significantly reduced head circumference present already at birth and intellectual disability. Inconsistent features include hyperactivity, an expressive speech disorder, and epilepsy. Here, we provide a brief overview on this rare disorder pertinent for clinicians.